Ashika Group receives SEBI's in-principle approval to launch mutual funds in India

▴ Ashika Group
Ashika Group today announced that it has received in-principle approval from the Securities and Exchange Board of India (SEBI) to act sponsor and set up Ashika Mutual fund, marking a significant strategic milestone in its growth journey.

Hyderabad, 31st December 2025: Ashika Group today announced that it has received in-principle approval from the Securities and Exchange Board of India (SEBI) to act sponsor and set up Ashika Mutual fund, marking a significant strategic milestone in its growth journey. This approval reinforces the Group’s long-standing commitment to building institution-led, research-driven financial platforms and further strengthens its position in India’s rapidly expanding asset management landscape.​

 

This significant regulatory milestone allows the company to proceed with establishing an Asset Management Company (AMC) and preparing for the launch of the mutual fund schemes, subject to fulfilling SEBI’s final registration requirements and conditions.

 

The approval is a decisive step towards Ashika’s vision of creating a future-ready asset management ecosystem anchored in disciplined investing, robust governance, and long-term wealth creation.

 

Ashika Group’s foray into mutual funds builds on its extensive experience across capital markets and financial services, including retail & Institutional broking, investment banking, research advisory, global family office services, Alternative Asset Management and Private Equity. The proposed fund house aims to offer a thoughtfully curated range of investment schemes tailored to diverse investor needs, supported by strong research capabilities, disciplined risk management, and a governance-first approach.​

 

Commenting on the development, Pawan Jain, Chairman & Managing Director, Ashika Group, said “We are honoured to receive SEBI’s in-principle approval, which marks an important institutional milestone for Ashika Group and reinforces our long-standing belief in building enduring, governance-led financial platforms. The launch of Ashika Mutual Fund is a natural extension of our vision to contribute meaningfully to India’s evolving asset management ecosystem. As sponsors, our responsibility goes beyond performance — it is about creating a culture anchored in strong research, prudent risk management, and unwavering accountability, with the singular objective of delivering sustainable, long-term value for investors.”​

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026